Artificial intelligence-based prediction of esophageal adenocarcinoma risk in Barrett's esophagus patients: a literature review [0.03%]
基于人工智能的巴雷特食管患者食管腺癌风险预测：文献回顾
Priyanka Ahuja,Manesh Kumar Gangwani,Neha Ahuja et al.
Priyanka Ahuja et al.
Background and objective: Barrett's esophagus (BE) is the principal precursor lesion for esophageal adenocarcinoma (EAC), a malignancy with rising incidence and poor survival when diagnosed at advanced stages. Current scr...
Body mass index has no impact on complications and mortality for patients with stage IV pancreatic ductal adenocarcinoma [0.03%]
体 massa指数对IV期胰腺导管腺癌患者预后无影响
Ren Bryant,Hannah Darnell,Megan Hall et al.
Ren Bryant et al.
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of United States (USA) cancer death. Overweight and obesity developing into a growing global medical and socio-economic problem, affecting a...
Early surgery first for painful chronic pancreatitis with dilated main pancreatic duct: evidence awaiting integration into practice [0.03%]
急性慢性胰腺炎伴主胰管扩张的早期手术治疗：亟待将其临床疗效整合进实践中的证据
Vasileios K Mavroeidis
Vasileios K Mavroeidis
Emerging KRAS G12D inhibitor in the treatment of digestive system tumors: opportunities and challenges [0.03%]
治疗消化系统肿瘤的新兴KRAS G12D抑制剂：机遇与挑战
Xiaohan Wu,Hiromitsu Hayashi,Takumi Tanizaki et al.
Xiaohan Wu et al.
The KRAS G12D mutation, defined by substitution of glycine with aspartic acid at codon 12 within the GTP-binding region of the KRAS gene, occurs with particularly high prevalence in digestive system malignancies, especially pancreatic ducta...
Eosinophilic and mastocytic gastrointestinal diseases: current knowledge and controversy in histopathologic diagnosis [0.03%]
嗜酸性和肥大细胞胃肠病：组织病理诊断的现状与争议
Weibo Yu,Hanlin L Wang
Weibo Yu
Eosinophilic and mastocytic gastrointestinal (GI) diseases represent a spectrum of immune-mediated inflammatory disorders characterized by abnormal accumulation of eosinophils or mast cells in the GI tract. This review summarizes current kn...
Conjugated bilirubin in chronic liver disease: an underutilised prognostic biomarker?-a narrative review [0.03%]
慢性肝病中的结合胆红素：一个被低估的预后生物标志物？——叙述性综述
Elise Fawcett,Aloysious D Aravinthan
Elise Fawcett
Background and objective: Chronic liver disease (CLD) is a major global health burden, often progressing to cirrhosis, decompensation, and hepatocellular carcinoma. Prognostic models typically rely on serum total bilirubi...
Methodological challenges in mendelian randomization studies of immune cell phenotypes and autoimmune liver diseases [0.03%]
孟德尔随机化研究免疫细胞表型和自身免疫性肝病的方法学挑战
Qianlang Ren,Yanxin Zhao,Lanqing Ma
Qianlang Ren
Further insights into the causal link between immune cell phenotypes and autoimmune liver diseases [0.03%]
免疫细胞表型和自身免疫性肝病之间因果联系的进一步见解
Hongjie Zou,Xinghe Liang,Deke Jiang
Hongjie Zou
Adverse reactions of second-line tyrosine kinase inhibitors in advanced hepatocellular carcinoma treatment: a descriptive analysis from WHO-VigiAccess [0.03%]
肝细胞癌二线酪氨酸激酶抑制剂不良反应：来自WHO-VigiAccess的描述性分析
Weifan Sui,Yuxin Duan,Zefeng Cai et al.
Weifan Sui et al.
Background: Given the increasing use of targeted therapies in clinical practice, we aimed to determine the clinically actionable safety profiles of second-line tyrosine kinase inhibitors (TKIs) in advanced hepatocellular ...
Artificial intelligence-augmented small bowel capsule endoscopy for coeliac disease: a literature review on accuracy, workflow, and safety [0.03%]
基于人工智能的小肠胶囊内镜在乳糜泻中的应用：准确性、工作流程及安全性文献综述
Arkadeep Dhali,Rick Maity,Jyotirmoy Biswas et al.
Arkadeep Dhali et al.
Background and objective: Coeliac disease (CeD) is a common, underdiagnosed enteropathy with rising incidence and diagnostic delay. This literature review synthesises advances in small bowel capsule endoscopy (SBCE) and a...